What is the projected market valuation of the Radiopharmaceutical Synthesizer Market by 2035?

The Radiopharmaceutical Synthesizer Market is projected to reach a valuation of 5.002 USD Billion by 2035. Read More

What was the market valuation of the Radiopharmaceutical Synthesizer Market in 2024?

In 2024, the market valuation of the Radiopharmaceutical Synthesizer Market was 3.108 USD Billion. Read More

What is the expected CAGR for the Radiopharmaceutical Synthesizer Market during the forecast period 2025 - 2035?

The expected CAGR for the Radiopharmaceutical Synthesizer Market during the forecast period 2025 - 2035 is 4.42%. Read More

Which companies are considered key players in the Radiopharmaceutical Synthesizer Market?

Key players in the Radiopharmaceutical Synthesizer Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and others. Read More

What are the main modalities contributing to the Radiopharmaceutical Synthesizer Market?

The main modalities include PET, SPECT, and others, with PET projected to grow from 1.5 to 2.4 USD Billion. Read More

How does the oncology application segment perform in the Radiopharmaceutical Synthesizer Market?

The oncology application segment is expected to grow from 1.5 to 2.4 USD Billion, indicating strong demand. Read More

What is the market performance of the liquid-phase synthesis method in 2025?

The liquid-phase synthesis method is projected to grow from 1.2 to 1.8 USD Billion, reflecting its importance in the market. Read More

Which radioisotope is expected to show significant growth in the Radiopharmaceutical Synthesizer Market?

Fluorine-18 is expected to show growth from 0.8 to 0.9 USD Billion, highlighting its relevance in radiopharmaceuticals. Read More

What is the expected growth for the gas-phase synthesis method by 2035?

The gas-phase synthesis method is projected to grow from 0.6 to 0.9 USD Billion by 2035. Read More

How does the Radiopharmaceutical Synthesizer Market's growth compare across different applications?

The market shows varied growth across applications, with cardiology expected to rise from 0.9 to 1.4 USD Billion. Read More

Radiopharmaceutical Synthesizer Market

ID: MRFR/Pharma/25982-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Radiopharmaceutical Synthesizer Market Research Report By Modality (PET, SPECT, Others), By Application (Oncology, Cardiology, Neurology, Others), By Radioisotope (Fluorine-18, Carbon-11, Gallium-68, Others), By Synthesis Method (Solid-Phase, Liquid-Phase, Gas-Phase, Others) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Radiopharmaceutical Synthesizer Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.42%

2024 Market Size$ 3.11 Billion

2025 Market Size$ 3.25 Billion

2035 Market Size$ 5 Billion

Key Players

GE Healthcare

Siemens Healthineers

Philips Healthcare

Elekta

Bracco Imaging

Lantheus Medical Imaging

Trends

Technological Advancements
Regulatory Compliance
Personalized Medicine

Opportunities

Growing Focus on Personalized Medicine
Increasing Demand for Diagnostic Imaging
Regulatory Support and Funding Initiatives

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Modality (USD Billion)
  1. 4.1.1 PET
  2. 4.1.2 SPECT
  3. 4.1.3 Others
2. 4.2 Healthcare, BY Application (USD Billion)
  1. 4.2.1 Oncology
  2. 4.2.2 Cardiology
  3. 4.2.3 Neurology
  4. 4.2.4 Others
3. 4.3 Healthcare, BY Radioisotope (USD Billion)
  1. 4.3.1 Fluorine-18
  2. 4.3.2 Carbon-11
  3. 4.3.3 Gallium-68
  4. 4.3.4 Others
4. 4.4 Healthcare, BY Synthesis Method (USD Billion)
  1. 4.4.1 Solid-Phase
  2. 4.4.2 Liquid-Phase
  3. 4.4.3 Gas-Phase
  4. 4.4.4 Others
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 GE Healthcare (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Siemens Healthineers (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Philips Healthcare (NL)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Elekta (SE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bracco Imaging (IT)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Lantheus Medical Imaging (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 NorthStar Medical Radioisotopes (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Radiopharma (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 IThemba LABS (ZA)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY MODALITY
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY RADIOISOTOPE
6. 6.6 US MARKET ANALYSIS BY SYNTHESIS METHOD
7. 6.7 CANADA MARKET ANALYSIS BY MODALITY
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY RADIOISOTOPE
10. 6.10 CANADA MARKET ANALYSIS BY SYNTHESIS METHOD
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY MODALITY
13. 6.13 GERMANY MARKET ANALYSIS BY APPLICATION
14. 6.14 GERMANY MARKET ANALYSIS BY RADIOISOTOPE
15. 6.15 GERMANY MARKET ANALYSIS BY SYNTHESIS METHOD
16. 6.16 UK MARKET ANALYSIS BY MODALITY
17. 6.17 UK MARKET ANALYSIS BY APPLICATION
18. 6.18 UK MARKET ANALYSIS BY RADIOISOTOPE
19. 6.19 UK MARKET ANALYSIS BY SYNTHESIS METHOD
20. 6.20 FRANCE MARKET ANALYSIS BY MODALITY
21. 6.21 FRANCE MARKET ANALYSIS BY APPLICATION
22. 6.22 FRANCE MARKET ANALYSIS BY RADIOISOTOPE
23. 6.23 FRANCE MARKET ANALYSIS BY SYNTHESIS METHOD
24. 6.24 RUSSIA MARKET ANALYSIS BY MODALITY
25. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION
26. 6.26 RUSSIA MARKET ANALYSIS BY RADIOISOTOPE
27. 6.27 RUSSIA MARKET ANALYSIS BY SYNTHESIS METHOD
28. 6.28 ITALY MARKET ANALYSIS BY MODALITY
29. 6.29 ITALY MARKET ANALYSIS BY APPLICATION
30. 6.30 ITALY MARKET ANALYSIS BY RADIOISOTOPE
31. 6.31 ITALY MARKET ANALYSIS BY SYNTHESIS METHOD
32. 6.32 SPAIN MARKET ANALYSIS BY MODALITY
33. 6.33 SPAIN MARKET ANALYSIS BY APPLICATION
34. 6.34 SPAIN MARKET ANALYSIS BY RADIOISOTOPE
35. 6.35 SPAIN MARKET ANALYSIS BY SYNTHESIS METHOD
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY MODALITY
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY RADIOISOTOPE
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY SYNTHESIS METHOD
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY MODALITY
42. 6.42 CHINA MARKET ANALYSIS BY APPLICATION
43. 6.43 CHINA MARKET ANALYSIS BY RADIOISOTOPE
44. 6.44 CHINA MARKET ANALYSIS BY SYNTHESIS METHOD
45. 6.45 INDIA MARKET ANALYSIS BY MODALITY
46. 6.46 INDIA MARKET ANALYSIS BY APPLICATION
47. 6.47 INDIA MARKET ANALYSIS BY RADIOISOTOPE
48. 6.48 INDIA MARKET ANALYSIS BY SYNTHESIS METHOD
49. 6.49 JAPAN MARKET ANALYSIS BY MODALITY
50. 6.50 JAPAN MARKET ANALYSIS BY APPLICATION
51. 6.51 JAPAN MARKET ANALYSIS BY RADIOISOTOPE
52. 6.52 JAPAN MARKET ANALYSIS BY SYNTHESIS METHOD
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY MODALITY
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY RADIOISOTOPE
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY SYNTHESIS METHOD
57. 6.57 MALAYSIA MARKET ANALYSIS BY MODALITY
58. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION
59. 6.59 MALAYSIA MARKET ANALYSIS BY RADIOISOTOPE
60. 6.60 MALAYSIA MARKET ANALYSIS BY SYNTHESIS METHOD
61. 6.61 THAILAND MARKET ANALYSIS BY MODALITY
62. 6.62 THAILAND MARKET ANALYSIS BY APPLICATION
63. 6.63 THAILAND MARKET ANALYSIS BY RADIOISOTOPE
64. 6.64 THAILAND MARKET ANALYSIS BY SYNTHESIS METHOD
65. 6.65 INDONESIA MARKET ANALYSIS BY MODALITY
66. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION
67. 6.67 INDONESIA MARKET ANALYSIS BY RADIOISOTOPE
68. 6.68 INDONESIA MARKET ANALYSIS BY SYNTHESIS METHOD
69. 6.69 REST OF APAC MARKET ANALYSIS BY MODALITY
70. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION
71. 6.71 REST OF APAC MARKET ANALYSIS BY RADIOISOTOPE
72. 6.72 REST OF APAC MARKET ANALYSIS BY SYNTHESIS METHOD
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY MODALITY
75. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION
76. 6.76 BRAZIL MARKET ANALYSIS BY RADIOISOTOPE
77. 6.77 BRAZIL MARKET ANALYSIS BY SYNTHESIS METHOD
78. 6.78 MEXICO MARKET ANALYSIS BY MODALITY
79. 6.79 MEXICO MARKET ANALYSIS BY APPLICATION
80. 6.80 MEXICO MARKET ANALYSIS BY RADIOISOTOPE
81. 6.81 MEXICO MARKET ANALYSIS BY SYNTHESIS METHOD
82. 6.82 ARGENTINA MARKET ANALYSIS BY MODALITY
83. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION
84. 6.84 ARGENTINA MARKET ANALYSIS BY RADIOISOTOPE
85. 6.85 ARGENTINA MARKET ANALYSIS BY SYNTHESIS METHOD
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODALITY
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY RADIOISOTOPE
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY SYNTHESIS METHOD
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY MODALITY
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY RADIOISOTOPE
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY SYNTHESIS METHOD
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY MODALITY
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY RADIOISOTOPE
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY SYNTHESIS METHOD
99. 6.99 REST OF MEA MARKET ANALYSIS BY MODALITY
100. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION
101. 6.101 REST OF MEA MARKET ANALYSIS BY RADIOISOTOPE
102. 6.102 REST OF MEA MARKET ANALYSIS BY SYNTHESIS METHOD
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY MODALITY, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY MODALITY, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY RADIOISOTOPE, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY RADIOISOTOPE, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY SYNTHESIS METHOD, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY SYNTHESIS METHOD, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.2.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.3.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.4.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.5.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.6.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.7.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.8.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.9.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.10.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.11.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.12.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.13.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.14.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.15.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.16.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.17.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.18.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.19.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.20.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.21.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.22.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.23.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.24.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.25.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.26.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.27.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.28.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.29.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY MODALITY, 2025-2035 (USD Billion)
  2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY RADIOISOTOPE, 2025-2035 (USD Billion)
  4. 7.30.4 BY SYNTHESIS METHOD, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Radiopharmaceutical Synthesizer Market Segmentation

Radiopharmaceutical Synthesizer Market By Modality (USD Billion, 2025-2035)

PET
SPECT
Others

Radiopharmaceutical Synthesizer Market By Application (USD Billion, 2025-2035)

Oncology
Cardiology
Neurology
Others

Radiopharmaceutical Synthesizer Market By Radioisotope (USD Billion, 2025-2035)

Fluorine-18
Carbon-11
Gallium-68
Others

Radiopharmaceutical Synthesizer Market By Synthesis Method (USD Billion, 2025-2035)

Solid-Phase
Liquid-Phase
Gas-Phase
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”